Global /Italy /Healthcare /Drug Manufacturers - Specialty & Generic /ERFO

Laboratorio Farmaceutico Erfo S.p.A.

ERFO

• MIL: ERFO • Delayed

1.17EUR -5.3%

1.34 USD

As of 6 June 2026, Laboratorio Farmaceutico Erfo S.p.A. has a market cap of $12.17M USD, ranking #40212 globally and #342 in Italy. It ranks #3586 in the Healthcare sector, and #240 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

40212

Country Rank

342

Sector Rank

3586

Industry Rank

240

Key Stats

Market Cap

$12.17MUSD

10.48M EUR

Enterprise Value

$12.9MUSD

11.2M EUR

Revenue (TTM)

$11.3MUSD

9.73M EUR

EBITDA (TTM)

$2.11MUSD

1.83M EUR

Net Income (TTM)

$855.99KUSD

736.97K EUR

EBITDA Margin

19%

Profit Margin

7.6%

PE Ratio

14.2

Forward PE

10.3

PS Ratio

1.1

PB Ratio

1.3

EV/EBITDA

6.1

Company Profile

Country (HQ)

Italy

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Alessandro Cute open_in_new

Employees

Founded

2013

Website

erfo.it open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-5.3%	-2.8%	12%	-10%	-22%	-16%	13%	7%	-31%

News

Markets

Exchange	Ticker	Price	Quotes
Borsa Italiana (MIL / BIT) MIC: XMIL PRIMARY	ERFO Laboratorio Farmaceutico Erfo SpA ISIN: IT0005497885 Shares Out.: Shares Outstanding: 8.52M¹ TV: TradingView: MIL: ERFO SA: Stock Analysis: BIT: ERFO YF: Yahoo Finance: ERFO.MI GF: Google Finance: BIT: ERFO BA: Barron's: ERFO MS: Morningstar: XMIL: ERFO	1.17 EUR	TV: TradingView: MIL: ERFO SA: Stock Analysis: BIT: ERFO YF: Yahoo Finance: ERFO.MI GF: Google Finance: BIT: ERFO BA: Barron's: ERFO MS: Morningstar: XMIL: ERFO

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Laboratorio Farmaceutico Erfo S.p.A.

Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services. In addition, the company engages in development and franchising of boutique fitness centers. Laboratorio Farmaceutico Erfo S.p.A. was founded in 2013 and is based in Villafranca Tirrena, Italy.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Italy)

Name	Market Cap (USD) diff.	PE	Country
Pharmanutra S.p.A. MIL: PHN	$868.59M 747.82M EUR 7K%	37.4	Italy
Enervit S.p.A. MIL: ENV	$101.93M 87.75M EUR 737%	19.8	Italy

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 309K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 243K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 130K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 91K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 90K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 75K%	80.6	China

chevron_leftBack